{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T09:55:56Z","timestamp":1790589356132,"version":"4.1.0"},"reference-count":16,"publisher":"Walter de Gruyter GmbH","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_cclm-2026-0487_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Serial laboratory measurements are routinely obtained in critically ill patients, yet prognostic assessment often relies on isolated baseline values. Using procalcitonin (PCT) as a worked example, we evaluated whether simple kinetic features derived from early serial measurements were associated with 28-day mortality in ICU patients with suspected sepsis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_cclm-2026-0487_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analysed a retrospective ICU cohort in which PCT measurements were aligned to the first available value (day 0) and evaluated over an early observation window (days 0\u20135). PCT concentrations were log-transformed [log(1\u00a0+\u00a0PCT)]. Two kinetic features were derived: the slope of log-transformed PCT over time and the area under the curve (AUC). Bayesian logistic regression models were fitted to predict 28-day mortality using (i)\u00a0baseline PCT, (ii) early PCT kinetic features, and (iii) kinetic features with selected clinical covariates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_cclm-2026-0487_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The analytic cohort comprised 128 ICU patients, with a 28-day mortality of 32.8\u202f%. Early PCT trajectories demonstrated substantial inter-individual heterogeneity. In the kinetics-only model, higher AUC was associated with increased mortality (odds ratio [OR] 1.83, 95\u202f% credible interval [CrI] 1.25\u20132.74), while slope showed greater uncertainty (OR 1.42, 95\u202f% CrI 0.98\u20132.12). The kinetics-only model achieved the highest expected log predictive density, although differences relative to the baseline PCT model were modest and uncertain. Addition of selected clinical covariates did not materially improve predictive performance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_cclm-2026-0487_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Simple kinetic summaries derived from early serial biomarker measurements may retain prognostic information beyond baseline values alone. Using PCT as an example, this study illustrates a pragmatic approach to incorporating early laboratory dynamics into prognostic assessment in critically ill patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/cclm-2026-0487","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T13:59:03Z","timestamp":1782136743000},"page":"2452-2460","source":"Crossref","is-referenced-by-count":0,"title":["Early procalcitonin kinetics and 28-day mortality in critical illness: a pragmatic Bayesian modelling approach"],"prefix":"10.1515","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2280-132X","authenticated-orcid":false,"given":"Aaqilah","family":"Fataar","sequence":"first","affiliation":[{"name":"Division of Chemical Pathology, Department of Pathology, Faculty of Medicine and Health Sciences , Stellenbosch University , Cape Town , South Africa"},{"name":"Division of Chemical Pathology, National Health Laboratory Service , Tygerberg Hospital , Cape Town , South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7621-4679","authenticated-orcid":false,"given":"Annalise E.","family":"Zemlin","sequence":"additional","affiliation":[{"name":"Division of Chemical Pathology, Department of Pathology, Faculty of Medicine and Health Sciences , Stellenbosch University , Cape Town , South Africa"},{"name":"Division of Chemical Pathology, National Health Laboratory Service , Tygerberg Hospital , Cape Town , South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsie C.","family":"Kruger","sequence":"additional","affiliation":[{"name":"Division of Chemical Pathology, Department of Pathology, Faculty of Medicine and Health Sciences , Stellenbosch University , Cape Town , South Africa"},{"name":"Division of Chemical Pathology, National Health Laboratory Service , Tygerberg Hospital , Cape Town , South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"2026092809015507415_j_cclm-2026-0487_ref_001","doi-asserted-by":"crossref","unstructured":"Ziegelstein, R. Personomics: the missing link in the evolution from precision medicine to personalized medicine. J\u00a0Personalized Med 2017;7:11. https:\/\/doi.org\/10.3390\/jpm7040011.","DOI":"10.3390\/jpm7040011"},{"key":"2026092809015507415_j_cclm-2026-0487_ref_002","doi-asserted-by":"crossref","unstructured":"Santacroce, E, D\u2019Angerio, M, Ciobanu, AL, Masini, L, Lo Tartaro, D, Coloretti, I, et al.. Advances and challenges in sepsis management: modern tools and future directions. Cells 2024;13:439. https:\/\/doi.org\/10.3390\/cells13050439.","DOI":"10.3390\/cells13050439"},{"key":"2026092809015507415_j_cclm-2026-0487_ref_003","doi-asserted-by":"crossref","unstructured":"Wilson, S, Steele, S, Adeli, K. Innovative technological advancements in laboratory medicine: predicting the lab of the future. Biotechnol Biotechnol Equip 2022;36:S5\u201317. https:\/\/doi.org\/10.1080\/13102818.2021.2011413.","DOI":"10.1080\/13102818.2021.2011413"},{"key":"2026092809015507415_j_cclm-2026-0487_ref_004","doi-asserted-by":"crossref","unstructured":"Singer, M, Deutschman, CS, Seymour, CW, Shankar-Hari, M, Annane, D, Bauer, M, et al.. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016;315:801\u201310. https:\/\/doi.org\/10.1001\/jama.2016.0287.","DOI":"10.1001\/jama.2016.0287"},{"key":"2026092809015507415_j_cclm-2026-0487_ref_005","doi-asserted-by":"crossref","unstructured":"Assicot, M, Gendrel, D, Carsin, H, Raymond, J, Guilbaud, J, Bohuon, C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993;341:515\u20138. https:\/\/doi.org\/10.1016\/0140-6736(93)90277-n.","DOI":"10.1016\/0140-6736(93)90277-N"},{"key":"2026092809015507415_j_cclm-2026-0487_ref_006","unstructured":"Schuetz, P, Wirz, Y, Sager, R, Christ-Crain, M, Stolz, D, Tamm, M, et al.. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev 2017;10:CD007498."},{"key":"2026092809015507415_j_cclm-2026-0487_ref_007","doi-asserted-by":"crossref","unstructured":"Liu, D, Su, L, Han, G, Yan, P, Xie, L. Prognostic value of procalcitonin in adult patients with sepsis: a systematic review and meta-analysis. PLoS One 2015;10:e0129450. https:\/\/doi.org\/10.1371\/journal.pone.0129450.","DOI":"10.1371\/journal.pone.0129450"},{"key":"2026092809015507415_j_cclm-2026-0487_ref_008","doi-asserted-by":"crossref","unstructured":"Zaccone, V, Falsetti, L, Nitti, C, Gentili, T, Marchetti, A, Piersantelli, MN, et al.. The prognostic role of procalcitonin in critically ill patients admitted in a medical stepdown unit: a retrospective cohort study. Sci Rep 2020;10:4531. https:\/\/doi.org\/10.1038\/s41598-020-61457-6.","DOI":"10.1038\/s41598-020-61457-6"},{"key":"2026092809015507415_j_cclm-2026-0487_ref_009","doi-asserted-by":"crossref","unstructured":"Wang, X, Lin, S, Zhong, M, Song, J. The procalcitonin trajectory as an effective tool for identifying sepsis patients at high risk of mortality. Crit Care 2024;28:312. https:\/\/doi.org\/10.1186\/s13054-024-05100-0.","DOI":"10.1186\/s13054-024-05100-0"},{"key":"2026092809015507415_j_cclm-2026-0487_ref_010","doi-asserted-by":"crossref","unstructured":"Rizopoulos, D. Joint models for longitudinal and time-to-event data with applications in R, 1st ed. New York: Chapman and Hall\/CRC; 2012.","DOI":"10.1201\/b12208"},{"key":"2026092809015507415_j_cclm-2026-0487_ref_011","doi-asserted-by":"crossref","unstructured":"Fataar, A, Zemlin, AE, Kruger, EC. Prognostic utility of serial procalcitonin measurements in ICU sepsis: a laboratory-led modelling approach in a resource-limited setting. Clin Chem Lab Med 2026;64:741\u20137. https:\/\/doi.org\/10.1515\/cclm-2025-0778.","DOI":"10.1515\/cclm-2025-0778"},{"key":"2026092809015507415_j_cclm-2026-0487_ref_012","doi-asserted-by":"crossref","unstructured":"Gelman, A, Carlin, JB, Stern, HS, Dunson, DB, Vehtari, A, Rubin, DB. Bayesian data analysis, 3rd ed. New York: Chapman and Hall\/CRC; 2013.","DOI":"10.1201\/b16018"},{"key":"2026092809015507415_j_cclm-2026-0487_ref_013","doi-asserted-by":"crossref","unstructured":"Steyerberg, EW. Clinical prediction models: a practical approach to development, validation, and updating, 2nd ed. Cham (CH): Springer; 2019.","DOI":"10.1007\/978-3-030-16399-0"},{"key":"2026092809015507415_j_cclm-2026-0487_ref_014","doi-asserted-by":"crossref","unstructured":"Schuetz, P, Chiappa, V, Briel, M, Greenwald, JL. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch Intern Med 2011;171:1322\u201331. https:\/\/doi.org\/10.1001\/archinternmed.2011.318.","DOI":"10.1001\/archinternmed.2011.318"},{"key":"2026092809015507415_j_cclm-2026-0487_ref_015","doi-asserted-by":"crossref","unstructured":"Schuetz, P, Birkhahn, R, Sherwin, R, Jones, AE, Singer, A, Kline, JA, et al.. Serial procalcitonin predicts mortality in severe sepsis patients: results from the multicenter procalcitonin monitoring sepsis (MOSES) study. Crit Care Med 2017;45:781\u20139. https:\/\/doi.org\/10.1097\/ccm.0000000000002321.","DOI":"10.1097\/CCM.0000000000002321"},{"key":"2026092809015507415_j_cclm-2026-0487_ref_016","doi-asserted-by":"crossref","unstructured":"Plebani, M, Coskun, A. Promoting value-based laboratory medicine: moving towards an innovative model of clinical laboratory. Clin Chim Acta 2025;572:120269. https:\/\/doi.org\/10.1016\/j.cca.2025.120269.","DOI":"10.1016\/j.cca.2025.120269"}],"container-title":["Clinical Chemistry and Laboratory Medicine (CCLM)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2026-0487\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2026-0487\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T09:07:05Z","timestamp":1790586425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2026-0487\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":16,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,7,9]]},"published-print":{"date-parts":[[2026,10,26]]}},"alternative-id":["10.1515\/cclm-2026-0487"],"URL":"https:\/\/doi.org\/10.1515\/cclm-2026-0487","relation":{},"ISSN":["1434-6621","1437-4331"],"issn-type":[{"value":"1434-6621","type":"print"},{"value":"1437-4331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]}}}